What does CUSIP 03969T109 represent in this 13F holders report?

CUSIP 03969T109 is the security identifier for ARCT - Arcturus Therapeutics Holdings Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held ARCT - Arcturus Therapeutics Holdings Inc. - Common Stock in Q4 2021?

133 institutional investors reported ARCT - Arcturus Therapeutics Holdings Inc. - Common Stock for Q4 2021. Use the holders table for investor-level position and value details.

Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT)

CUSIP: 03969T109

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class: Equity / Common Stock
Shares outstanding: 28,412,394
Total 13F shares: 19,955,158
Share change: +910,525
Total reported value: $736,203,155
Put/Call ratio: 31%
Price per share: $37.01
Number of holders: 133
Value change: +$29,436,784
Number of buys: 53
Number of sells: 76

Quarterly Holders Quick Answers

What is CUSIP 03969T109?
CUSIP 03969T109 identifies ARCT - Arcturus Therapeutics Holdings Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2022
Previous quarter: Q3 2021

Recent filing periods for CUSIP 03969T109:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ARCT - Arcturus Therapeutics Holdings Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FEDERATED HERMES, INC.	13F	Company	11%	3,045,288	$145,504,000	—	30 Sep 2021	13F
ARK Investment Management LLC	13F	Company	8.9%	2,529,509	$120,860,000	—	30 Sep 2021	13F
BlackRock Finance, Inc.	13F	Company	6.1%	1,720,708	$82,216,000	—	30 Sep 2021	13F
STATE STREET CORP	13F	Company	5.2%	1,470,341	$70,253,000	—	30 Sep 2021	13F
Sumitomo Mitsui Trust Group, Inc.	13F	Company	4.8%	1,358,532	$64,911,000	—	30 Sep 2021	13F
Amova Asset Management Americas, Inc.	13F	Company	4.8%	1,358,532	$62,492,000	—	30 Sep 2021	13F
VANGUARD GROUP INC	13F	Company	3.9%	1,113,951	$53,225,000	—	30 Sep 2021	13F
FMR LLC	13F	Company	3.8%	1,072,977	$51,267,000	—	30 Sep 2021	13F
Bank Julius Baer & Co. Ltd, Zurich	13F	Company	2.4%	680,249	$32,502,000	—	30 Sep 2021	13F
Ultragenyx Pharmaceutical Inc.	3/4/5	Director	— class O/S missing	1,400,000	$26,208,420	—	10 Aug 2021	3/4/5
ACT CAPITAL MANAGEMENT, LLC	13F	Company	1.6%	455,300	$21,754,000	—	30 Sep 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.4%	400,369	$19,129,000	—	30 Sep 2021	13F
JPMORGAN CHASE & CO	13F	Company	0.82%	233,833	$11,172,000	—	30 Sep 2021	13F
NORTHERN TRUST CORP	13F	Company	0.72%	205,270	$9,808,000	—	30 Sep 2021	13F
Rafferty Asset Management, LLC	13F	Company	0.56%	158,883	$7,591,000	—	30 Sep 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.53%	149,560	$7,146,000	—	30 Sep 2021	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.51%	143,772	$6,870,000	—	30 Sep 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.5%	141,128	$6,743,000	—	30 Sep 2021	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.49%	139,449	$6,664,000	—	30 Sep 2021	13F
MORGAN STANLEY	13F	Company	0.48%	137,572	$6,573,000	—	30 Sep 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.32%	90,633	$4,935,000	—	30 Sep 2021	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.35%	100,627	$4,808,000	—	30 Sep 2021	13F
D. E. Shaw & Co., Inc.	13F	Company	0.34%	95,766	$4,575,000	—	30 Sep 2021	13F
UBS Group AG	13F	Company	0.32%	89,745	$4,288,000	—	30 Sep 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.31%	89,075	$4,256,000	—	30 Sep 2021	13F
Integral Health Asset Management, LLC	13F	Company	0.3%	85,000	$4,061,000	—	30 Sep 2021	13F
Altium Capital Management LLC	13F	Company	0.28%	80,000	$3,822,000	—	30 Sep 2021	13F
ROYCE & ASSOCIATES LP	13F	Company	0.28%	79,836	$3,815,000	—	30 Sep 2021	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.27%	78,082	$3,731,000	—	30 Sep 2021	13F
Bank of New York Mellon Corp	13F	Company	0.27%	76,777	$3,669,000	—	30 Sep 2021	13F
Granahan Investment Management, LLC	13F	Company	0.26%	73,177	$3,496,000	—	30 Sep 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.25%	71,737	$3,428,000	—	30 Sep 2021	13F
CITIGROUP INC	13F	Company	0.23%	64,636	$3,088,000	—	30 Sep 2021	13F
PICTET ASSET MANAGEMENT SA	13F	Company	0.21%	60,930	$2,911,000	—	30 Sep 2021	13F
JACOB ASSET MANAGEMENT OF NEW YORK LLC	13F	Company	0.2%	56,155	$2,683,000	—	30 Sep 2021	13F
JANE STREET GROUP, LLC	13F	Company	0.19%	55,298	$2,642,000	—	30 Sep 2021	13F
PDT Partners, LLC	13F	Company	0.17%	49,500	$2,365,000	—	30 Sep 2021	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.17%	48,161	$2,301,000	—	30 Sep 2021	13F
SHELTON CAPITAL MANAGEMENT	13F	Company	0.17%	48,000	$2,293,000	—	30 Sep 2021	13F
Swiss National Bank	13F	Company	0.16%	46,300	$2,212,000	—	30 Sep 2021	13F
Koss-Olinger Consulting, LLC	13F	Company	0.15%	43,800	$2,093,000	—	30 Sep 2021	13F
Vontobel Holding Ltd.	13F	Company	0.14%	40,167	$1,919,000	—	30 Sep 2021	13F
Marshall Wace North America L.P.	13F	Company	0.14%	39,972	$1,909,000	—	30 Sep 2021	13F
Bellevue Group AG	13F	Company	0.12%	34,500	$1,648,000	—	30 Sep 2021	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.12%	34,000	$1,625,000	—	30 Sep 2021	13F
ALPS ADVISORS INC	13F	Company	0.11%	32,259	$1,541,000	—	30 Sep 2021	13F
Snowden Capital Advisors LLC	13F	Company	0.11%	32,015	$1,529,677	—	30 Sep 2021	13F
Hennion & Walsh Asset Management, Inc.	13F	Company	0.11%	30,013	$1,434,000	—	30 Sep 2021	13F
RHUMBLINE ADVISERS	13F	Company	0.1%	29,642	$1,416,000	—	30 Sep 2021	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.1%	28,640	$1,368,000	—	30 Sep 2021	13F

Institutional Holders of Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT) as of Q4 2021

As of 31 Dec 2021, Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT) was held by 133 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,955,158 shares. The largest 10 holders included FEDERATED HERMES, INC., ARK Investment Management LLC, STATE STREET CORP, BlackRock Inc., Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc., VANGUARD GROUP INC, FMR LLC, ACT CAPITAL MANAGEMENT, LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 133 institutional shareholders reporting positions in this security for the Q4 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders

150

Q4 2021 holders

133

Holder diff

-17

Investor	Q3 2021 Shares	Q4 2021 Shares	Share Diff	Share Chg %	Q3 2021 Value $	Q4 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.